Din Fynske Sygeplejerske ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 4.2% 12.4% 22.9%  
Credit score (0-100)  0 0 47 18 3  
Credit rating  N/A N/A BBB BB B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 1,438 261 -39.7  
EBITDA  0.0 0.0 767 -209 -40.5  
EBIT  0.0 0.0 767 -209 -40.5  
Pre-tax profit (PTP)  0.0 0.0 767.7 -219.5 13.0  
Net earnings  0.0 0.0 596.4 -173.5 10.1  
Pre-tax profit without non-rec. items  0.0 0.0 768 -220 13.0  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 636 406 357  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 55.6  
Balance sheet total (assets)  0.0 0.0 845 431 421  

Net Debt  0.0 0.0 -806 -380 -321  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 1,438 261 -39.7  
Gross profit growth  0.0% 0.0% 0.0% -81.8% 0.0%  
Employees  0 0 0 0 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 -671.1 -469.8 -0.8  
Balance sheet total (assets)  0 0 845 431 421  
Balance sheet change%  0.0% 0.0% 0.0% -49.0% -2.4%  
Added value  0.0 0.0 1,438.3 261.2 -39.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 1.0 -1.0 -2.0  

Profitability 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 53.3% -79.9% 101.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 91.4% -32.6% 4.2%  
ROI %  0.0% 0.0% 121.4% -39.9% 4.3%  
ROE %  0.0% 0.0% 93.7% -33.3% 2.6%  

Solidity 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 0.0% 75.3% 94.2% 84.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -105.0% 181.9% 794.0%  
Gearing %  0.0% 0.0% 0.0% 0.0% 15.6%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 17.0%  

Liquidity 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 4.0 17.2 6.6  
Current Ratio  0.0 0.0 4.0 17.2 6.6  
Cash and cash equivalent  0.0 0.0 805.5 379.5 376.9  

Capital use efficiency 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 407.1 131.0 -8.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 -40  
Employee expenses / employee  0 0 0 0 -1  
EBITDA / employee  0 0 0 0 -40  
EBIT / employee  0 0 0 0 -40  
Net earnings / employee  0 0 0 0 10